Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

StemCells Inc (NASDAQ:STEM)

During the Trading Day
0.40 +0.012 / +3.09%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
0.40 0.00 / 0.00%
Volume: 200.00
Health Technology

Company Description

StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA.

Contact Information

StemCells, Inc.
7707 Gateway Boulevard
Newark California 94560
P:(510) 456-4000
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Martin M. McGlynnChief Executive Officer & Director
Ian John MasseyPresident & Chief Operating Officer
Gregory T. SchiffmanChief Financial Officer & Executive Vice President
Stephen HuhnChief Medical Officer & VP-Clinical Research
Ann TsukamotoEVP-Scientific & Strategic Alliances